<DOC>
	<DOCNO>NCT00376636</DOCNO>
	<brief_summary>This study conduct investigate effect oral renin inhibitor SPP635 blood pressure patient mild moderate hypertension .</brief_summary>
	<brief_title>Phase IIa Safety Efficacy Study SPP635 Mild Moderate Hypertension</brief_title>
	<detailed_description>Renin-Angiotensin system blockade well establish target treatment high blood pressure . Blocking system initial step , however , rather new concept could implement recently availability novel , oral , renin inhibitor . This study investigate safety efficacy novel oral renin inhibitor , SPP635 .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<criteria>male female patient mild moderate hypertension female patient childbearing potential breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2006</verification_date>
</DOC>